COMPUTATIONAL & LABORATORY STUDY OF P16/INK4 MUTATIONS
计算型
基本信息
- 批准号:6789371
- 负责人:
- 金额:$ 23.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:biochemical evolutioncell cyclecell growth regulationcyclin dependent kinaseflow cytometryfunctional /structural genomicsgreen fluorescent proteinsmathematical modelmodel design /developmentmolecular biology information systemmolecular cloningnucleic acid sequencepoint mutationprotein structure functionsite directed mutagenesistumor suppressor genesyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Missense base substitutions may or may not
result in a functionally altered protein. Interpreting the biological effects
of amino acid (AA) substitutions in cancer-related genes is critical in a
variety of contexts. Clinical cancer geneticists often must decide whether a
previously unknown allelic variant causes disease. Reliable functional assays
usually are not available. The objectives of the proposed work are to develop
and test a model for predicting the biological consequences and clinical
relevance of missense mutations in the p16 gene by detailed study of
evolutionary substitution patterns and protein structure. Aligned AA and
nucleotide sequences are often compared to infer information about protein
function. Detailed computational analyses are rarely performed on genes
associated with human diseases, but preliminary data indicate they can improve
upon simple sequence alignment in predicting function. Specific aims are: 1) To
collect p16 evolutionary and mutational data sufficient for refining a model
that predicts the functional consequences of AA substitutions; to clone and
sequence new p16 sequences in order to expand the database so that it is large
enough for sufficiently detailed computations. 2) To test in vitro the cell
cycle arrest and cdk binding of missense variants of p16. Logistic regression
will be used to establish a computational model that predicts loss of function.
Initial calculations of high conservation correctly predicted mutant function
in 75-80 percent of tested codons, and low conservation correctly predicted
wild type function in 85-90 percent. We predict that evolutionary parameters
and structural features provide independent information for predicting
functional changes. 3) To integrate computational and laboratory data in
differentiating the biology of p16 and related proteins. p16 is used as a
prototype for study because of its role in Familial Melanoma; missense
mutations occur whose functional consequences are unknown; reliable functional
assays exist; and a crystal structure is known, so data for mutational
spectrum, evolution, structure, and function can be correlated. These studies
should be generalizable to the interpretation of mutations in other
cancer-related genes and to other single nucleotide polymorphisms (SNPs) found
throughout the genome.
DESCRIPTION (provided by applicant): Missense base substitutions may or may not
result in a functionally altered protein. Interpreting the biological effects
of amino acid (AA) substitutions in cancer-related genes is critical in a
variety of contexts. Clinical cancer geneticists often must decide whether a
previously unknown allelic variant causes disease. Reliable functional assays
usually are not available. The objectives of the proposed work are to develop
and test a model for predicting the biological consequences and clinical
relevance of missense mutations in the p16 gene by detailed study of
evolutionary substitution patterns and protein structure. Aligned AA and
nucleotide sequences are often compared to infer information about protein
function. Detailed computational analyses are rarely performed on genes
associated with human diseases, but preliminary data indicate they can improve
upon simple sequence alignment in predicting function. Specific aims are: 1) To
collect p16 evolutionary and mutational data sufficient for refining a model
that predicts the functional consequences of AA substitutions; to clone and
sequence new p16 sequences in order to expand the database so that it is large
enough for sufficiently detailed computations. 2) To test in vitro the cell
cycle arrest and cdk binding of missense variants of p16. Logistic regression
will be used to establish a computational model that predicts loss of function.
Initial calculations of high conservation correctly predicted mutant function
in 75-80 percent of tested codons, and low conservation correctly predicted
wild type function in 85-90 percent. We predict that evolutionary parameters
and structural features provide independent information for predicting
functional changes. 3) To integrate computational and laboratory data in
differentiating the biology of p16 and related proteins. p16 is used as a
prototype for study because of its role in Familial Melanoma; missense
mutations occur whose functional consequences are unknown; reliable functional
assays exist; and a crystal structure is known, so data for mutational
spectrum, evolution, structure, and function can be correlated. These studies
should be generalizable to the interpretation of mutations in other
cancer-related genes and to other single nucleotide polymorphisms (SNPs) found
throughout the genome.
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.
MSH2 变体 N127S 和 G322D 的不确定致病性对它们的分类提出了挑战。
- DOI:10.1002/ijc.23573
- 发表时间:2008
- 期刊:
- 影响因子:6.4
- 作者:Ollila,Saara;DermadiBebek,Denis;Greenblatt,Marc;Nyström,Minna
- 通讯作者:Nyström,Minna
Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes.
- DOI:10.1002/humu.20889
- 发表时间:2008-11
- 期刊:
- 影响因子:3.9
- 作者:Greenblatt, Marc S.;Brody, Lawrence C.;Foulkes, William D.;Genuardi, Maurizio;Hofstra, Robert M. W.;Olivier, Magali;Plon, Sharon E.;Sijmons, Rolf H.;Sinilnikova, Olga;Spurdle, Amanda B.
- 通讯作者:Spurdle, Amanda B.
In silico analysis of missense substitutions using sequence-alignment based methods.
- DOI:10.1002/humu.20892
- 发表时间:2008-11
- 期刊:
- 影响因子:3.9
- 作者:Tavtigian, Sean V.;Greenblatt, Marc S.;Lesueur, Fabienne;Byrnes, Graham B.
- 通讯作者:Byrnes, Graham B.
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
- DOI:10.1002/humu.20880
- 发表时间:2008-11
- 期刊:
- 影响因子:3.9
- 作者:Plon, Sharon E.;Eccles, Diana M.;Easton, Douglas;Foulkes, William D.;Genuardi, Maurizio;Greenblatt, Marc S.;Hogervorst, Frans B. L.;Hoogerbrugge, Nicoline;Spurdle, Amanda B.;Tavtigian, Sean V.
- 通讯作者:Tavtigian, Sean V.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC S GREENBLATT其他文献
MARC S GREENBLATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC S GREENBLATT', 18)}}的其他基金
InSiGHT-ClinGen Polyposis/Colon Cancer Variant Curation Expert Panel
InSiGHT-ClinGen 息肉病/结肠癌变异治疗专家组
- 批准号:
10670880 - 财政年份:2021
- 资助金额:
$ 23.6万 - 项目类别:
InSiGHT-ClinGen Polyposis/Colon Cancer Variant Curation Expert Panel
InSiGHT-ClinGen 息肉病/结肠癌变异治疗专家组
- 批准号:
10426086 - 财政年份:2021
- 资助金额:
$ 23.6万 - 项目类别:
Classifying DNA Mismatch Repair Gene Variants of Unknown Significance
对意义不明的 DNA 错配修复基因变异进行分类
- 批准号:
8819520 - 财政年份:2013
- 资助金额:
$ 23.6万 - 项目类别:
Classifying DNA Mismatch Repair Gene Variants of Unknown Significance
对意义不明的 DNA 错配修复基因变异进行分类
- 批准号:
8628802 - 财政年份:2013
- 资助金额:
$ 23.6万 - 项目类别:
Classifying DNA Mismatch Repair Gene Variants of Unknown Significance
对意义不明的 DNA 错配修复基因变异进行分类
- 批准号:
8439776 - 财政年份:2013
- 资助金额:
$ 23.6万 - 项目类别:
MUTATIONS IN THE HPRT GENE, SMOKING AND LUNG CANCER
HPRT 基因突变、吸烟与肺癌
- 批准号:
6115951 - 财政年份:1998
- 资助金额:
$ 23.6万 - 项目类别:
MUTATIONS IN THE HPRT GENE, SMOKING AND LUNG CANCER
HPRT 基因突变、吸烟与肺癌
- 批准号:
6247051 - 财政年份:1997
- 资助金额:
$ 23.6万 - 项目类别:
相似海外基金
Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission
研究泛素化调节的细胞周期事件支撑疟疾传播
- 批准号:
MR/Y013174/1 - 财政年份:2024
- 资助金额:
$ 23.6万 - 项目类别:
Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
- 批准号:
MR/Y01264X/1 - 财政年份:2024
- 资助金额:
$ 23.6万 - 项目类别:
Research Grant
Conference: FASEB Yeast Chromosome and Cell Cycle Conference 2024
会议:2024 年 FASEB 酵母染色体和细胞周期会议
- 批准号:
2403471 - 财政年份:2024
- 资助金额:
$ 23.6万 - 项目类别:
Standard Grant
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别:
Fellowship
Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
- 批准号:
10714634 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别:
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别:
Cell cycle control of cell polarity and fate in epidermal morphogenesis
表皮形态发生中细胞极性和命运的细胞周期控制
- 批准号:
10608036 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别:
Cell cycle-dependent dynein adaptor switching
细胞周期依赖性动力蛋白适配器转换
- 批准号:
23KF0285 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Regulation of Cell Cycle progression by the nuclear envelope
核膜对细胞周期进程的调节
- 批准号:
10659597 - 财政年份:2023
- 资助金额:
$ 23.6万 - 项目类别: